# Efficacy and Safety of Pregabalin Combined With Educational and Behavioral Intervention for Bladder Pain Syndrome/Interstitial Cystitis

> **NCT07752134** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Bladder Pain Syndrome
- Pregabalin
- Educational Behavioral Intervention
- Urinary Urgency

## Interventions

- **BEHAVIORAL:** Educational and Behavioral Management Program (EBMP)
- **DRUG:** Pregabalin

## Key facts

- **NCT ID:** NCT07752134
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-31
- **Primary completion:** 2027-10-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07752134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07752134, "Efficacy and Safety of Pregabalin Combined With Educational and Behavioral Intervention for Bladder Pain Syndrome/Interstitial Cystitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07752134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
